Aurora Sheboygan Prices – Solid Tumor Mutations by Next-Generation Sequencing: $2,960.00

Solid Tumor Mutations by Next-Generation Sequencing (NGS) is an advanced diagnostic test offered at Aurora Medical Center in Sheboygan County, priced at $2,960. This test analyzes the genetic mutations present in solid tumors, equipping oncologists with essential information to tailor personalized cancer treatment plans. The fee typically covers the costs of tumor tissue processing, sophisticated genetic sequencing, and interpretation of results by specialized laboratory staff. Since this is a high-complexity, cutting-edge diagnostic service, patients are encouraged to request an itemized estimate to clarify what is included, confirm insurance coverage, and ask about potential additional costs such as specimen collection or consultations.

Cost Breakdown

• NGS Laboratory Processing and Sequencing: The primary component of the fee, involving advanced laboratory technology to decode genetic information.
• Pathology Review: Examination of the tumor tissue sample by a pathologist before sequencing.
• Interpretation & Reporting: Analysis of sequencing data and generation of a clinical report for your provider.
• Administrative Fees: Costs related to specimen handling and documentation.

Associated Costs to Consider

• Tumor biopsy or tissue collection (if not already performed)
• Follow-up consultations to review results
• Additional targeted tests based on NGS findings
• Potential out-of-network laboratory fees

Insurance & Payment Advice

• Check with your insurer to verify coverage for NGS testing and any pre-authorization requirements.
• Request a detailed, itemized bill to review charges and ensure accuracy.
• Ask about available financial assistance programs or payment plans if you are uninsured or underinsured.
• Be aware that genetic testing coverage varies widely among insurance plans.

Frequently Asked Questions

• What is Solid Tumor Mutations by Next-Generation Sequencing?
  This is a diagnostic test that examines the genetic mutations in solid tumors to help guide personalized cancer treatment.
• Why is this test important for my cancer treatment?
  The test provides detailed genetic information about your tumor, enabling your doctor to select therapies more likely to be effective for your specific cancer type.
• Does the $2,960 fee include the biopsy or tissue collection?
  Generally, the fee covers only the sequencing and analysis. Biopsy or tissue collection may be billed separately.
• Will my insurance cover this test?
  Coverage varies depending on your insurance plan and medical necessity. Confirm with your provider and insurer before proceeding.
• How long does it take to receive results?
  Results are typically available within 2 to 4 weeks, but timing may vary depending on lab processing and case complexity.
• Are there any risks or side effects from this test?
  The sequencing itself poses no risk, but obtaining the tumor tissue may involve risks associated with standard biopsy procedures.
• What should I do if the test is not covered by insurance?
  Ask the hospital about financial assistance, payment plans, or self-pay discounts, and explore third-party support resources if needed.
• How will the results impact my treatment?
  Your oncologist may use the genetic information to choose targeted therapies or clinical trials that are more likely to benefit you.
• Can this test be done with an existing tissue sample?
  Yes, if there is sufficient, high-quality tumor tissue available from a prior biopsy or surgery, it may be used for NGS testing.
• Are there additional costs after the NGS test?
  Depending on the findings, your doctor may recommend further tests or consultations, which could incur separate charges.

Aurora Medical Center in Sheboygan County offers a specialized medical service known as Solid Tumor Mutations by Next-Generation Sequencing (NGS), priced at $2,960. This advanced diagnostic test is designed to analyze genetic mutations in solid tumors, providing crucial information that can guide personalized treatment plans for cancer patients. By examining the genetic makeup of a tumor, healthcare providers can better understand the specific characteristics of the cancer, potentially leading to more effective and targeted therapies. The cost reflects the complexity and precision of the technology used in sequencing, which is a cutting-edge tool in the field of oncology.

What is Solid Tumor Mutations by Next-Generation Sequencing? – Solid Tumor Mutations by Next-Generation Sequencing is a diagnostic test that analyzes the genetic mutations present in solid tumors to aid in the development of personalized cancer treatment plans.

Why is this test important for cancer treatment? – This test is important because it provides detailed genetic information about a tumor, allowing healthcare providers to tailor treatments that are more likely to be effective for the specific cancer type.

How does Next-Generation Sequencing work? – Next-Generation Sequencing works by rapidly sequencing large amounts of DNA, enabling the identification of genetic mutations within a tumor that may influence cancer behavior and treatment response.

What types of cancer can benefit from this test? – Many types of solid tumors, including those in the breast, lung, colon, and other organs, can benefit from this test as it helps in understanding the genetic drivers of the cancer.

Is the test covered by insurance? – Coverage for this test varies by insurance provider and plan, so it is important for patients to check with their insurance company to determine if the test is covered and what out-of-pocket costs may apply.

How long does it take to get results from the test? – The time to receive results can vary, but typically, patients can expect to receive their test results within a few weeks after the sample is collected.

Are there any risks associated with the test? – The test itself involves analyzing a sample of the tumor, which may require a biopsy, a procedure that carries standard medical risks such as infection or bleeding, but the sequencing process is non-invasive.

Who should consider getting this test? – Patients diagnosed with solid tumors who are seeking personalized treatment options may consider this test, especially if their oncologist recommends it as part of their treatment planning.

What should patients do if they have questions about the test? – Patients with questions about the test should consult their healthcare provider or oncologist, who can provide detailed information and guidance based on their individual medical needs.